Food and drug authorities will take responsibility for criminal IP investigations, as government re-shuffle continues. It’s good news for pharma IP owners – others may have questions
Following successful invalidation petitions lodged by Vivo against the German company, industry sources tell IAM that Oppo, Xiaomi and Meizu also face SEP assertions in specialised IP courts
Netac’s own killer patent is set to expire later this year. But according to demand letters circulating Chinese media, the memory maker's IP team is now partnering with a patent pool formed by Panasonic, Toshiba and SanDisk
Amid reports of US patent owners facing delays, practitioners say extra caution and busy dockets are possible explanations
Shenzhen BGI was once the biggest purchaser of Illumina’s gene sequencing machines. Now the two are on opposite sides of an expanding patent battle
Minoru Fujiki (pictured, right) has taken charge of the fund operator’s patent business after the departure of founding CEO Shigeharu Yoshii (centre)
Our week-long series on the US-China trade dispute concludes, as deal-makers working on the ground say licence transactions and tech transfer are still happening, but big uncertainties remain
New reforms have significantly strengthened trade secret protection in China, providing rights holders with a welcome boost.
Some of the major news stories carried on the IAM platform from March to mid-May.
IP owners in China see plenty of uncertainty ahead in no-win scenario of escalating technology tensions
US authorities are considering Huawei-style export bans targeting Chinese firms including DJI and Hikvision, according to reports. Both have past IP ties with big American tech firms
Harsh US sanctions are on hold for 90 days, but uncertainty now clouds the whole supply chain. For the company's and China's goal of greater tech self-sufficiency, there is no turning back
Analysis of US patent assignment data shows cross-border transactions are still happening in semiconductors and other high-tech sectors. Proposed legislation could lead to greater scrutiny
Settlement with Immersion and newly-minted Huawei agreement both came on the heels of China litigation, while IPVALUE licence announced yesterday keeps the Korean giant out of court